Published in Trends Biochem Sci on October 01, 1997
The MDM2 gene amplification database. Nucleic Acids Res (1998) 4.64
Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol (1999) 3.40
A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc Natl Acad Sci U S A (2001) 1.88
DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol Cell Biol (2005) 1.56
Evidence that dynamin-2 functions as a signal-transducing GTPase. J Cell Biol (2000) 1.53
Molecular pathogenesis of oral squamous carcinoma. Mol Pathol (2000) 1.44
The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress. Mol Cell Biol (2000) 1.30
Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J Virol (2009) 1.18
Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300. J Virol (1999) 1.11
Updates on p53: modulation of p53 degradation as a therapeutic approach. Br J Cancer (2008) 1.07
pRB induces Sp1 activity by relieving inhibition mediated by MDM2. Proc Natl Acad Sci U S A (2001) 0.89
Reversible aggregation plays a crucial role on the folding landscape of p53 core domain. Biophys J (2004) 0.88
Colorectal carcinomas arising in the hyperplastic polyposis syndrome progress through the chromosomal instability pathway. Am J Pathol (2000) 0.87
Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene. Nucleic Acids Res (2000) 0.85
Effects of in vitro fertilization and embryo culture on TRP53 and Bax expression in B6 mouse embryos. Reprod Biol Endocrinol (2006) 0.83
Udu deficiency activates DNA damage checkpoint. Mol Biol Cell (2009) 0.82
p73 competes with p53 and attenuates its response in a human ovarian cancer cell line. Nucleic Acids Res (2000) 0.81
Molecular dynamic simulation insights into the normal state and restoration of p53 function. Int J Mol Sci (2012) 0.78
The p53 pathway. J Pathol (1999) 6.79
The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res (1994) 3.28
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol (1991) 2.71
Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer (1991) 2.52
Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology (1993) 2.52
p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! J Pathol (1994) 2.41
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology (1991) 2.32
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol (1993) 2.07
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet (1991) 1.95
The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol (1997) 1.86
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol (1987) 1.80
Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology (1988) 1.76
Do we really need a higher necropsy rate? Lancet (1999) 1.71
Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene (1995) 1.62
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol (1991) 1.58
Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci (1995) 1.57
Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res (2001) 1.57
The complexities of proliferating cell nuclear antigen. Histopathology (1992) 1.57
Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem J (1995) 1.49
The epidermal growth factor receptor in human pancreatic cancer. J Pathol (1992) 1.47
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol (1991) 1.46
Koch's postulates revisited. J Pathol (1991) 1.46
The p53 response to ionising radiation in adult and developing murine tissues. Oncogene (1996) 1.46
Ki67--structure, function, and new antibodies. J Pathol (1992) 1.45
APC expression in normal human tissues. J Pathol (1997) 1.44
Comparison of manual data coding errors in two hospitals. J Clin Pathol (1986) 1.42
Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay. J Clin Microbiol (1993) 1.41
The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology (1993) 1.40
Identification of the antigen recognized by the monoclonal antibody BU31 as lamins A and C. J Pathol (1996) 1.38
The p53 tumour suppressor gene. Br J Surg (1998) 1.37
Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology (1992) 1.33
New marker of B lymphocytes, MB2: comparison with other lymphocyte subset markers active in conventionally processed tissue sections. J Clin Pathol (1987) 1.30
Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology (1992) 1.30
Expression of the 'dead box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J Pathol (1998) 1.23
Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int (1987) 1.22
Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer (2000) 1.21
Do septins have a role in cancer? Br J Cancer (2005) 1.20
Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol (1989) 1.18
Rapid technique of DNA-DNA in situ hybridisation on formalin fixed tissue sections using microwave irradiation. J Clin Pathol (1987) 1.17
Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology (1991) 1.17
The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med (2000) 1.16
Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci (1996) 1.14
Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues. Am J Pathol (1996) 1.12
Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease. Histopathology (1989) 1.11
Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest (1993) 1.10
Enteroendocrine cell hyperplasia, carcinoid tumours and adenocarcinoma in long-standing ulcerative colitis. Histopathology (1986) 1.10
Do aggressive subclones within primary colorectal cancer give rise to liver metastases? Int J Colorectal Dis (1989) 1.10
Enzyme-linked immunosorbent assay and enzyme-linked coagulation assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual-label antibodies. J Clin Microbiol (1994) 1.08
Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens. Cancer Res (1994) 1.08
Demonstration of DNA damage/repair in individual cells using in situ end labelling: association of p53 with sites of DNA damage. J Pathol (1995) 1.07
p53--integrating the complexity. J Pathol (1996) 1.06
The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol (2000) 1.05
Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology (1993) 1.02
Epithelial tumors metastatic to the uterine cervix. A study of 33 cases and review of the literature. Cancer (1986) 1.01
Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut (1995) 1.01
Antibodies to T cell antigen receptor beta chain families detect monoclonal T cell proliferation. Lancet (1986) 1.00
Acetone/periodate-lysine-paraformaldehyde (PLP) fixation and improved morphology of cryostat sections for immunohistochemistry. Histopathology (1987) 0.94
Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res (1993) 0.93
Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol (2000) 0.91
Ki67: from antibody to molecule to understanding? Clin Mol Pathol (1995) 0.90
The role of the p53 protein in the apoptotic response. Philos Trans R Soc Lond B Biol Sci (1994) 0.90
p53 expression is common in malignant mesothelioma. Histopathology (1992) 0.90
The biochemical characterization of the DNA binding activity of pKi67. J Pathol (2000) 0.88
Control of differentiation in a rectal adenocarcinoma cell line: the role of diffusable and cell-associated factors. J Pathol (1991) 0.88
Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding. Exp Cell Res (1999) 0.87
Fen1 expression: a novel marker for cell proliferation. J Pathol (1998) 0.87
A nude mouse xenograft model of fetal intestine development and differentiation. Development (1992) 0.86
The Trp53 pathway is induced in vivo by low doses of gamma radiation. Radiat Res (2001) 0.85
Classification of primary gut lymphomas. Lancet (1988) 0.85
Extraction of DNA from small sections of frozen tissue with simultaneous histological examination. J Clin Pathol (1988) 0.85
Does the p53 up-regulated Gadd45 protein have a role in excision repair? Science (1995) 0.84
A functional model of adult human prostate epithelium. The role of androgens and stroma in architectural organisation and the maintenance of differentiated secretory function. J Cell Sci (1992) 0.83
Why is p53 protein stabilized in neoplasia? Some answers but many more questions? J Pathol (1998) 0.83
Malignant lymphoma with eosinophilia of the gastrointestinal tract. Histopathology (1987) 0.83
Growth factors and oncogenes in pancreatic cancer. Baillieres Clin Gastroenterol (1990) 0.83
Proliferating cell nuclear antigen immunolocalization in gastro-intestinal epithelia. Digestion (1991) 0.82
The immunocytochemical detection of p53 protein in cytological specimens: technical considerations. Cytopathology (1994) 0.82
Simultaneous presentation of T- and B-cell malignant lymphoma with bcl-2 gene involvement. Blood (1989) 0.82
The association between cell proliferation and apoptosis: studies using the cell cycle-associated proteins Ki67 and DNA polymerase alpha. J Pathol (1996) 0.81
An immunochemical analysis of mdm2 expression in human breast cancer and the identification of a growth-regulated cross-reacting species p170. J Pathol (1998) 0.81
The yeast two-hybrid system for identifying protein-protein interactions. J Pathol (2003) 0.80
Molecular and cellular themes in inflammation and immunology. J Pathol (2008) 0.79
Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc Res (1993) 0.79
Management of localized non-Hodgkin's lymphoma: the experience at St. Bartholomew's Hospital 1972-1985. Hematol Oncol (1989) 0.79
The p53 tumour suppressor gene and tumour prognosis: is there a relationship? J Pathol (1995) 0.79
Tumour diagnosis. Nature (1994) 0.79
Gadd45 mutations are uncommon in human tumour cell lines. Cell Prolif (2000) 0.78
A monoclonal antibody (anti-L-35) which reacts with human osteoclasts and cells of the mononuclear phagocyte system. Br J Exp Pathol (1988) 0.78
Expression of the nuclear membrane protein statin in cycling cells. J Pathol (1993) 0.78
Epithelial-mesenchymal interactions can influence the phenotype of carcinoma metastases in the mucosa of the intestine. J Pathol (1990) 0.78
The clinical relevance of the p53 tumour suppressor gene. Cytopathology (1994) 0.78
Measuring a cell's response to stress: the p53 pathway. Genome Biol (2000) 0.77
Modeling the growth of Listeria monocytogenes in cured ready-to-eat processed meat products by manipulation of sodium chloride, sodium diacetate, potassium lactate, and product moisture content. J Food Prot (2002) 0.77
Challenges to improving health risk communication in the 21st century: a discussion. J Natl Cancer Inst Monogr (1999) 0.77
The gut-associated lymphoid tissue and its tumours. Curr Top Pathol (1990) 0.77
The fibroblast growth factor and receptor multigene families. J Pathol (1993) 0.77
Analysis of apoptosis in tissue sections. Methods Mol Biol (2001) 0.77